BioPharma Dive Jan 28, 2026 Lilly bets on Seamless, delving further into genetic medicine for hearing loss
Lonza News Jan 28, 2026 Lonza still intends to sell its capsules and health ingredients business - Endpoints News
BioPharma Dive Jan 28, 2026 Drugs for cancer, arthritis and HIV on Medicare’s list for 2028 price cuts
Cell Jan 28, 2026 A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulator
Cell Jan 28, 2026 AAVLINK: A potent DNA-recombination method for large cargo delivery in gene therapy